trending Market Intelligence /marketintelligence/en/news-insights/trending/72MDez_qnIewE0Zf1FXGBg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Becton Dickinson fiscal Q3 earnings up 5.8% YOY

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Becton Dickinson fiscal Q3 earnings up 5.8% YOY

Becton Dickinson and Co. said its adjusted EPS for the fiscal third quarter ended June 30 rose 5.8% to $3.08 from $2.91 a year earlier.

The S&P Global Market Intelligence consensus normalized EPS estimate for the fiscal quarter was $3.06.

Revenue for the quarter was $4.35 billion, up 1.7% year over year from $4.28 billion. Research and development expenses for the three-month period were up 2.1% to $282 million.

On a GAAP basis, the Franklin Lakes, N.J.-based medical device company booked a fiscal third-quarter net income applicable to common shareholders of $413 million, or $1.51 per share, down 25.7% from $556 million, or $2.03 per share, in the year-ago period.

Becton Dickinson reaffirmed its revenue and earnings guidance for the full year. The company continues to expect fiscal 2019 revenues to increase by 8% to 9%, and it expects adjusted EPS to be between $11.65 and $11.75.

The S&P Global Market Intelligence consensus normalized EPS estimate for the full fiscal year is $11.70.

Becton Dickinson develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products worldwide.